D. Taber

发表

Big Data, Predictive Analytics, and Quality Improvement in Kidney Transplantation: A Proof of Concept

T. Srinivas, P. Mauldin, D. Taber, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Patient Attitudes Toward Mobile Phone-Based Health Monitoring: Questionnaire Study Among Kidney Transplant Recipients

Martina Mueller, Ana K. Weiland, Martina Mueller, 2013, Journal of medical Internet research.

Unfractionated and Low-Molecular-Weight Heparin for Bridging Patients with Left Ventricular Assist Device: An Event-Based Analysis

D. Taber, A. D. Rabon, W. Uber, 2021, ASAIO journal.

Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left Ventricular Assist Devices.

D. Taber, W. Uber, B. Houston, 2019, Journal of the American College of Cardiology.

Clinical Management Strategies and Implications for Parenteral Nutrition Drug Shortages in Adult Patients

Brian P. McKinzie, T. Hassig, D. Taber, 2014, Pharmacotherapy.

Timing of Factor VIIa in Liver Transplantation Impacts Cost and Clinical Outcomes

K. Chavin, P. Baliga, D. Taber, 2013, Pharmacotherapy.

Clinical and Economic Analysis of Delayed Administration of Antithymocyte Globulin for Induction Therapy in Kidney Transplantation

C. Bratton, K. Chavin, P. Baliga, 2013, Progress in transplantation.

Concern for Lost Income Following Donation Deters Some Patients From Talking to Potential Living Donors

J. Schold, D. Mandelbrot, J. Rodrigue, 2016, Progress in transplantation.

Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine

T. Srinivas, D. Taber, Mahmoud Kamel, 2016, World journal of transplantation.

Prospective Randomized Controlled Trial of Rabbit Antithymocyte Globulin Compared With IL-2 Receptor Antagonist Induction Therapy in Kidney Transplantation

T. Srinivas, K. Chavin, P. Baliga, 2014, Annals of surgery.

Impact of Pharmacist-Driven Transitions of Care Interventions on Post-hospital Outcomes Among Patients With Coronary Artery Disease: A Systematic Review.

R. Axon, D. Taber, E. Weeda, 2021, Journal of pharmacy practice.

Cardiovascular risk factors contribute to disparities in graft outcomes in African American renal transplant recipients: A retrospective analysis

K. Hunt, K. Chavin, P. Baliga, 2015, Blood pressure.

Efficacy of induction therapy on acute rejection and graft outcomes in African American kidney transplantation

M. Egidi, A. Lin, C. Bratton, 2010, Clinical transplantation.

The Impact of Cardiovascular Disease Risk Factors on Late Graft Outcome Disparities in Adult African American Kidney Transplant Recipients

D. Taber, 2020 .

Twenty years of evolving trends in racial disparities for adult kidney transplant recipients.

K. Hunt, M. Gebregziabher, L. Egede, 2016, Kidney international.

Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study

C. Bratton, K. Chavin, P. Baliga, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

A randomized, prospective comparison of transition to sirolimus‐based CNI‐minimization or withdrawal in African American kidney transplant recipients

T. Srinivas, C. Bratton, K. Chavin, 2016, Clinical transplantation.

Improving the perioperative value of care for vulnerable kidney transplant recipients.

A. Lin, C. Bratton, K. Chavin, 2013, Journal of the American College of Surgeons.

Potential differences in kidney allograft outcomes between ethnicities when converting to sirolimus base immunosuppression.

A. Lin, C. Bratton, K. Chavin, 2009, Transplantation proceedings.

Hypertension after Kidney Transplantation: A Pathophysiologic Approach

T. Srinivas, D. Taber, B. Thomas, 2013, Current Hypertension Reports.

Racial Disparity Outcomes in Patients Undergoing Hepatectomy: Is Baseline Kidney Function a Potential Explanation?

C. Bratton, K. Chavin, D. Taber, 2015, Progress in transplantation.

An Evaluation of Statin Use Among Patients with Type 2 Diabetes at High Risk of Cardiovascular Events Across Multiple Health Care Systems

R. Axon, M. Gebregziabher, D. Taber, 2020, Journal of managed care & specialty pharmacy.

Does African American Race Impact Statin Efficacy in Renal Transplant Outcomes?

L. Egede, D. Taber, Mukoso N. Ozieh, 2015, Medicine.

The concept of a composite perioperative quality index in kidney transplantation.

A. Lin, C. Bratton, K. Chavin, 2014, Journal of the American College of Surgeons.

Use of Renin—Angiotensin—Aldosterone System Inhibitors Within the First Eight to Twelve Weeks After Renal Transplantation

D. Taber, D. Jennings, 2008, The Annals of pharmacotherapy.

Are Thiazide Diuretics Safe and Effective Antihypertensive Therapy in Kidney Transplant Recipients?

L. Egede, C. Bratton, K. Chavin, 2013, American Journal of Nephrology.

Advanced models for improved prediction of opioid-related overdose and suicide events among Veterans using administrative healthcare data

R. Axon, M. Gebregziabher, D. Taber, 2021, Health Services and Outcomes Research Methodology.

Improving medication safety and cardiovascular risk factor control to mitigate disparities in African-American kidney transplant recipients: Design and methods

L. Egede, P. Baliga, D. Taber, 2017, Contemporary clinical trials communications.

The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C

C. Bratton, K. Chavin, P. Baliga, 2014, Clinical transplantation.

Investigating the Potential for Bias When Using a Widely Accepted Medication Adherence Measure to Predict Mortality

R. Axon, M. Gebregziabher, D. Taber, 2018, Pharmacotherapy.

Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease

J. Rogers, A. Lin, K. Chavin, 2004, Transplant infectious disease : an official journal of the Transplantation Society.

Outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients.

L. Egede, P. Baliga, D. Taber, 2017, American journal of surgery.

Use of Bone Health Protocol to Identify and Prevent Bone Disease in Kidney and Pancreas Transplant Recipients

D. Lawrence, K. Chavin, P. Baliga, 2007, The Annals of pharmacotherapy.

Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation

T. Srinivas, F. Treiber, D. DuBay, 2017, Transplantation.

Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients

D. Gerber, J. Fair, R. Shrestha, 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Hospital admissions and emergency department visits among kidney transplant recipients

D. DuBay, J. Bian, P. Mauldin, 2019, Clinical transplantation.

Ambulatory Care Coordination Issues With Dual Use Veteran Organ Transplant Recipients

L. Egede, D. Taber, S. Thrall, 2017, Progress in transplantation.

Building a business plan to support a transplantation pharmacy practice model.

A. Maldonado, E. Tichy, D. Taber, 2014, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

The impact of early corticosteroid withdrawal on graft survival in liver transplant recipients.

K. Chavin, P. Baliga, D. Taber, 2012, Transplantation proceedings.

Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients

J. Friedewald, M. Abecassis, Rohita Sinha, 2021, Clinical journal of the American Society of Nephrology : CJASN.

The impact of time‐varying clinical surrogates on disparities in African‐American kidney transplant recipients – a retrospective longitudinal cohort study

D. DuBay, P. Mauldin, D. Taber, 2018, Transplant international : official journal of the European Society for Organ Transplantation.

Inflammatory Biomarkers, Glycemic Variability, Hypoglycemia, and Renal Transplant Outcomes: Results of a Randomized Controlled Trial

K. Hunt, R. Carter, M. Egidi, 2014, Transplantation.

Utility of the Surgical Apgar Score in Kidney Transplantation

W. Stoll, D. Taber, L. Hebbar, 2016, Progress in transplantation.

Association Between Patient Satisfaction and Outcomes in Kidney Transplant

T. Srinivas, K. Chavin, P. Baliga, 2015, American journal of medical quality : the official journal of the American College of Medical Quality.

Clinical Outcomes Associated With the Early Postoperative Use of Heparin in Pancreas Transplantation

C. Bratton, K. Chavin, P. Baliga, 2014, Transplantation.

No Difference Between Smokers, Former Smokers, or Nonsmokers in the Operative Outcomes of Laparoscopic Donor Nephrectomies

A. Lin, C. Bratton, K. Chavin, 2009, Surgical laparoscopy, endoscopy & percutaneous techniques.

New chronic opioid use in Medicaid patients following cholecystectomy

M. Gebregziabher, J. McCauley, P. Mauldin, 2022, Surgery open science.

Influence of mild obesity on outcome of simultaneous pancreas and kidney transplantation

J. Rogers, A. Lin, K. Chavin, 2003, Journal of Gastrointestinal Surgery.

Impact of Anesthesiologist Experience on Early Outcomes in Adult Orthotopic Liver Transplantation.

W. Stoll, D. Taber, L. Hebbar, 2021, Transplantation proceedings.

Mobile Health in Solid Organ Transplant: The Time Is Now

F. Treiber, J. McElligott, D. Taber, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Patient‐reported medication adherence and tolerability: Results of a prospective observational study

D. Taber, H. Meadows, J. Fleming, 2020, JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.

Randomized controlled trial assessing the impact of everolimus and low‐exposure tacrolimus on graft outcomes in kidney transplant recipients

T. Srinivas, D. Taber, Z. Su, 2019, Clinical transplantation.

Evaluation of Estimated and Measured Creatinine Clearances for Predicting the Pharmacokinetics of Vancomycin in Adult Liver Transplant Recipients

G. Malat, D. Taber, R. Dupuis, 2003, Therapeutic drug monitoring.

A Critical Analysis of the Specific Pharmacist Interventions and Risk Assessments During the 12-Month TRANSAFE Rx Randomized Controlled Trial

M. Gebregziabher, D. Taber, J. McGillicuddy, 2021, The Annals of pharmacotherapy.

Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management

D. Taber, N. Pilch, L. Bowman, 2020, Pharmacotherapy.

Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation.

A. Lin, C. Bratton, K. Chavin, 2008, Transplantation proceedings.

Alcohol withdrawal-related outcomes associated with gabapentin use in an inpatient psychiatric facility

D. Taber, S. Robert, Jeffrey Cluver, 2019, The mental health clinician.

Improved Patient Safety and Outcomes With a Comprehensive Interdisciplinary Improvement Initiative in Kidney Transplant Recipients

C. Bratton, K. Chavin, P. Baliga, 2013, American journal of medical quality : the official journal of the American College of Medical Quality.

Long‐standing diabetes mellitus and pancreas transplantation: An avenue to increase utilization of an ideal treatment modality

C. Bratton, P. Baliga, S. Nadig, 2019, Clinical transplantation.

The impact of diabetes on ethnic disparities seen in kidney transplantation.

L. Egede, K. Chavin, P. Baliga, 2013, Ethnicity & disease.

Significant Racial Differences in the Key Factors Associated with Early Graft Loss in Kidney Transplant Recipients

L. Egede, T. Srinivas, C. Bratton, 2014, American Journal of Nephrology.

Belatacept in Solid Organ Transplant: Review of Current Literature Across Transplant Types

D. Taber, H. Meadows, C. Mardis, 2018, Transplantation.

Disruptions in the Supply of Medications Used in Transplantation: Implications and Management Strategies for the Transplant Clinician

D. Taber, C. Fortier, J. Krisl, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Surgical Outcomes Improvement and Health Inequity in a Regional Quality Collaborative.

M. Gebregziabher, G. Magwood, P. Baliga, 2022, Journal of the American College of Surgeons.

The use of drotrecogin alfa (activated) in solid organ transplant patients: a case series

A. Lin, K. Chavin, P. Baliga, 2009, Transplant infectious disease : an official journal of the Transplantation Society.

Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients

D. DuBay, C. Bratton, P. Baliga, 2017, Annals of surgery.

Significant hospitalization cost savings to the payer with a pharmacist‐led mobile health intervention to improve medication safety in kidney transplant recipients

M. Gebregziabher, P. Mauldin, D. Taber, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A National Survey Assessing the Current Workforce of Transplant Pharmacists Across Accredited U.S. Solid Organ Transplant Programs

D. Taber, J. Trofe‐Clark, T. Kaiser, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Value of Solid Organ Transplant-Trained Pharmacists in Transplant Infectious Diseases

D. Taber, J. Trofe‐Clark, T. Kaiser, 2015, Current Infectious Disease Reports.

Impact of Type 1 and Type 2 Diabetes Mellitus on Pancreas Transplant Outcomes.

C. Bratton, K. Chavin, P. Baliga, 2019, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

Characterization of Potentially Unsafe Ambulatory Antibiotic Use and Associated Outcomes in an Adult Kidney Transplant Population

D. Taber, Cory E Fominaya, Lindsay M Avery, 2018, The Annals of pharmacotherapy.

Early aspirin therapy may reduce hepatic artery thrombosis in liver transplantation.

C. Bratton, K. Chavin, P. Baliga, 2013, Transplantation proceedings.

Clinical Outcomes and Costs Associated with In-hospital Biliary Complications After Liver Transplantation: a Cross-Sectional Analysis

K. Chavin, P. Baliga, S. Nadig, 2015, Journal of Gastrointestinal Surgery.

Hydroxyethyl Starch and Acute Kidney Injury in Orthotopic Liver Transplantation: A Single-Center Retrospective Review

B. Wolf, W. Hand, K. Chavin, 2015, Anesthesia and analgesia.

Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm

A. Lin, C. Bratton, K. Chavin, 2013, Clinical transplantation.

Predicting and preventing readmissions in kidney transplant recipients

C. Bratton, K. Chavin, P. Baliga, 2016, Clinical transplantation.

Can Preemptive Cytomegalovirus Monitoring Be As Effective As Universal Prophylaxis When Implemented As the Standard of Care in Patients at Moderate Risk?

S. Kuppachi, M. Egidi, K. Chavin, 2010, Transplantation.

Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection.

C. Bratton, K. Chavin, P. Baliga, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Virtual Crossmatching in Kidney Transplantation: The Wait Is Over.

D. DuBay, P. Baliga, S. Nadig, 2020, Journal of the American College of Surgeons.

A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients.

K. Hunt, M. Gebregziabher, L. Egede, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Transplant Pharmacy Services

R. Alloway, E. Tichy, D. Taber, 2014 .

Evolving Trends in Racial Disparities for Peri-Operative Outcomes with the New Kidney Allocation System (KAS) Implementation

D. DuBay, D. Taber, Daisy Sanchez, 2018, Journal of Racial and Ethnic Health Disparities.

Opioid Use Patterns in a Statewide Adult Medicaid Population Undergoing Elective Lumbar Spine Surgery

M. Gebregziabher, D. Taber, W. Moran, 2022, Spine.

Patterns of dispensed opioids after tonsillectomy in children and adolescents in South Carolina, United States, 2010-2017.

Jenna L. McCauley, M. Gebregziabher, K. Simpson, 2021, International journal of pediatric otorhinolaryngology.

A critical analysis of racial difference with mycophenolate mofetil (MMF) dosing, clinical outcomes and adverse effects in pediatric kidney transplant patients

J. Orak, K. Chavin, D. Taber, 2011, Clinical transplantation.

Review and Evaluation of mHealth Apps in Solid Organ Transplantation: Past, Present, and Future

C. Diamantidis, S. Docherty, Mclean D Pollock, 2022, Transplantation direct.

A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation

D. DuBay, S. Nadig, D. Taber, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Dosing Requirements of Extended-Release Tacrolimus (Astagraf XL) in African American Kidney Transplant Recipients Converted from Immediate Release Tacrolimus (AAAKTRS).

D. Taber, J. Fleming, M. A. Posadas Salas, 2019, Therapeutic drug monitoring.

Does Bioequivalence Between Modified Cyclosporine Formulations Translate into Equal Outcomes?

J. Rogers, A. Lin, K. Chavin, 2005, Transplantation.

African‐American Race Modifies the Influence of Tacrolimus Concentrations on Acute Rejection and Toxicity in Kidney Transplant Recipients

M. Gebregziabher, L. Egede, T. Srinivas, 2015, Pharmacotherapy.

Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled Trial

D. Taber, J. McGillicuddy, L. Sox, 2020, The Annals of pharmacotherapy.

Impact of CYP3A5 genotype on de-novo LCP tacrolimus dosing and monitoring in kidney transplantation

D. DuBay, D. Taber, N. Patel, 2023, Pharmacogenetics and genomics.

Etiologies and Outcomes Associated With Tacrolimus Levels Out of a Typical Range That Lead to High Variability in Kidney Transplant Recipients

D. Taber, Z. Su, J. McGillicuddy, 2021, Therapeutic drug monitoring.

Yes, We Still Need IL‐2 Receptor Antagonists

T. Srinivas, D. Taber, J. Fleming, 2016, American Journal of Transplantation.

Racial Comparisons of Everolimus Pharmacokinetics and Pharmacodynamics in Adult Kidney Transplant Recipients

T. Srinivas, C. Bratton, K. Chavin, 2013, Therapeutic drug monitoring.

Long-Term Outcome of Sirolimus Rescue in Kidney-Pancreas Transplantation

J. Rogers, A. Lin, K. Chavin, 2004, Transplantation.

Does treatment of cadaveric organ donors with desmopressin increase the likelihood of pancreas graft thrombosis? Results of a preliminary study.

J. Rogers, A. Lin, K. Chavin, 2004, Transplantation proceedings.

Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipients

C. Bratton, K. Chavin, P. Baliga, 2016, Pediatric Transplantation.

Evolution of the Role of the Transplant Pharmacist on the Multidisciplinary Transplant Team

R. Alloway, E. Tichy, D. Taber, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Renal Function Variability: An Independent Risk Factor for Graft Loss and Death following Kidney Transplantation

D. DuBay, P. Mauldin, D. Taber, 2018, American Journal of Nephrology.

The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation

K. Hunt, M. Gebregziabher, L. Egede, 2016, American Journal of Nephrology.

Phenotype of immunosuppression reduction after kidney transplantation

T. Srinivas, D. Taber, K. Soliman, 2020, Clinical transplantation.

Overall Graft Loss Versus Death-Censored Graft Loss: Unmasking the Magnitude of Racial Disparities in Outcomes Among US Kidney Transplant Recipients

Elizabeth H. Payne, M. Gebregziabher, L. Egede, 2017, Transplantation.

Incidence and impact of adverse drug events contributing to hospital readmissions in kidney transplant recipients

S. Nadig, D. Taber, J. McGillicuddy, 2017, Surgery.

Morbid obesity and functional status as predictors of surgical complication after renal transplantation.

K. Chavin, P. Baliga, D. Taber, 2017, American journal of surgery.

Association of High Burden of End-stage Kidney Disease With Decreased Kidney Transplant Rates With the Updated US Kidney Allocation Policy.

M. Casey, D. DuBay, P. Mauldin, 2021, JAMA surgery.

Incidence and patterns of persistent opioid use in children following appendectomy.

M. Gebregziabher, J. McCauley, P. Mauldin, 2022, Journal of pediatric surgery.

Prediction of medication non‐adherence and associated outcomes in pediatric kidney transplant recipients

P. Baliga, S. Nadig, D. Taber, 2015, Pediatric transplantation.

Sustainability of Improvements in Medication Adherence through a Mobile Health Intervention

F. Treiber, K. Chavin, P. Baliga, 2015, Progress in transplantation.

Mobile Health Medication Adherence and Blood Pressure Control in Renal Transplant Recipients: A Proof-of-Concept Randomized Controlled Trial

Rebecca A. Rock, F. Treiber, Mathew Gregoski, 2013, JMIR research protocols.

Medication Errors and Adverse Drug Events in Kidney Transplant Recipients: Incidence, Risk Factors, and Clinical Outcomes

C. Bratton, K. Chavin, P. Baliga, 2012, Pharmacotherapy.

Clinical and economic outcomes associated with medication errors in kidney transplantation.

F. Treiber, C. Bratton, K. Chavin, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Pharmacist‐led, technology‐assisted study to improve medication safety, cardiovascular risk factor control, and racial disparities in kidney transplant recipients

M. Gebregziabher, L. Egede, P. Baliga, 2018, Journal of the American College of Clinical Pharmacy : JAACP.

Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients

Elizabeth H. Payne, K. Hunt, M. Gebregziabher, 2016, Hypertension.

The Impact of Cardiovascular Disease and Risk Factor Treatment on Ethnic Disparities in Kidney Transplant

L. Egede, C. Bratton, K. Chavin, 2013, Journal of cardiovascular pharmacology and therapeutics.

Gastric bypass oxalosis in renal transplant: clinicopathologic correlates

T. Srinivas, P. Baliga, D. Taber, 2016 .

The Magnitude and Potential Causes of Sex Disparities in Statin Therapy in Veterans with Type 2 Diabetes: A 10-year Nationwide Longitudinal Cohort Study.

R. Axon, M. Gebregziabher, D. Taber, 2021, Women's health issues : official publication of the Jacobs Institute of Women's Health.

Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients.

D. Taber, J. McGillicuddy, S. Shenvi, 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Safety and Efficacy of Perioperative Sublingual Tacrolimus in Pancreas Transplant Compared With Oral Tacrolimus.

D. Taber, N. Patel, C. Perez, 2021, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

Costs and factors associated with heart failure following kidney transplantation – a single‐center retrospective cohort study

M. Casey, D. DuBay, J. Bian, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

Racial–Geographic Disparity in Lipid Management in Veterans with Type 2 Diabetes: A 10-Year Retrospective Cohort Study

R. Axon, M. Gebregziabher, D. Taber, 2019, Health equity.

Impact of the New Kidney Allocation System on Perioperative Outcomes and Costs in Kidney Transplantation.

D. DuBay, C. Bratton, K. Chavin, 2017, Journal of the American College of Surgeons.

Inclusion of Dynamic Clinical Data Improves the Predictive Performance of a 30-Day Readmission Risk Model in Kidney Transplantation

Mulugeta Gebregziabher, Leonard E. Egede, Titte R. Srinivas, 2015, Transplantation.

Preliminary assessment of safety and adherence to a once‐daily immunosuppression regimen in kidney transplantation: Results of a randomized controlled pilot study

D. DuBay, S. Nadig, D. Taber, 2020, Clinical transplantation.

Improving Transplant Medication Safety Through a Technology and Pharmacist Intervention (ISTEP): Protocol for a Cluster Randomized Controlled Trial

M. Gebregziabher, D. Taber, Cory E Fominaya, 2019, JMIR research protocols.

The Impact of Dual Health Care System Use for Obtaining Prescription Medications on Nonadherence in Veterans With Type 2 Diabetes

R. Axon, M. Gebregziabher, L. Egede, 2019, The Annals of pharmacotherapy.

The impact of race on metabolic, graft, and patient outcomes after pancreas transplantation.

A. Lin, P. Baliga, S. Nadig, 2021, American journal of surgery.

Pre‐existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation

L. Egede, K. Chavin, P. Baliga, 2013, Clinical transplantation.

Generic Immunosuppression: Deciphering the Message Our Patients are Receiving

K. Chavin, P. Baliga, D. Taber, 2012, The Annals of pharmacotherapy.

Evaluation of Racial Disparities in Pediatric Kidney Transplant.: Abstract# A345

K. Chavin, P. Baliga, S. Nadig, 2014 .

Graft outcomes in pediatric kidney transplantation: focus on the role of race.

J. Orak, K. Chavin, P. Baliga, 2012, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

Improving Transplant Medication Safety Through a Pharmacist-Empowered, Patient-Centered, mHealth-Based Intervention: TRANSAFE Rx Study Protocol

M. Gebregziabher, F. Treiber, D. Taber, 2018, JMIR research protocols.

A Dialysis Center Educational Video Intervention Increases Patient Self-Efficacy and Kidney Transplant Evaluations

M. Casey, D. DuBay, J. Rodrigue, 2021, Progress in transplantation.

Impact of a multidisciplinary multimodal opioid minimization initiative in kidney transplant recipients

P. Baliga, S. Nadig, D. Taber, 2020, Clinical transplantation.

Long-term Outcomes Following a Comprehensive Quality Assurance and Process Improvement Endeavor to Minimize Opioid Use After Kidney Transplant.

D. DuBay, P. Baliga, D. Taber, 2023, JAMA surgery.

The impact of pretransplant opioid exposure on healthcare utilization and costs in kidney transplant

D. Taber, J. Fleming, N. Pilch, 2020, Pharmacotherapy.

Medical Management Considerations for Patients With Lung Transplantation

D. Taber, R. Dupuis, A. Fann, 2001 .

Incidence and risk factors of hepatocellular carcinoma after orthotopic liver transplantation

K. Chavin, P. Baliga, D. Taber, 2017, Surgery.

Impact of Pharmacist Involvement in Early Identification and Enrollment in Patient Assistance Programs on CMV Outcomes in Transplantation

D. Taber, Jennifer Byrns, Nicole Pilch, 2016, Journal of pharmacy practice.

Creating a 13-year National Longitudinal Cohort of veterans with chronic kidney disease

M. Gebregziabher, L. Egede, D. Taber, 2019, BMC Nephrology.

Drug-drug interaction between chloramphenicol and tacrolimus in a liver transplant recipient.

D. Taber, R. Dupuis, K. Hollar, 2000, Transplantation proceedings.

Sulfonylureas as second line therapy for type 2 diabetes among veterans: Results from a National Longitudinal Cohort Study.

R. Axon, M. Gebregziabher, D. Taber, 2023, Primary care diabetes.

Effect of frailty on resource use and cost for Medicare patients.

Bryant A Seamon, A. Simpson, K. Simpson, 2018, Journal of comparative effectiveness research.

Pharmacist-Led Mobile Health Intervention and Transplant Medication Safety

M. Gebregziabher, D. Taber, Z. Su, 2021, Clinical journal of the American Society of Nephrology : CJASN.

The Expanded Role of the Transplant Pharmacist: A Ten Year Follow-up.

R. Alloway, D. Taber, E. Cohen, 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients.

F. Treiber, D. Taber, J. McGillicuddy, 2019, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Improving Transplant Patient Safety Through Pharmacist Discharge Medication Reconciliation

K. Chavin, D. Taber, J. McGillicuddy, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Risk factors and trajectories of opioid use following total knee replacement

M. Gebregziabher, P. Mauldin, D. Taber, 2022, Knee Surgery & Related Research.

Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: A report from the TRANSAFE Rx randomized controlled trial.

M. Gebregziabher, D. Taber, Z. Su, 2021, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Kidney transplant recipients' attitudes about using mobile health technology for managing and monitoring medication therapy.

F. Treiber, D. Taber, Frank A Treiber, 2016, Journal of the American Pharmacists Association : JAPhA.

It is time for board certification in transplant pharmacotherapy

A. Maldonado, D. Taber, J. Fleming, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Depression, Resource Utilization, and Outcomes Following Liver Transplant

C. Bratton, K. Chavin, P. Baliga, 2016, Progress in transplantation.

Joint effect of race/ethnicity or location of residence and sex on low density lipoprotein-cholesterol among veterans with type 2 diabetes: a 10-year retrospective cohort study

R. Axon, M. Gebregziabher, D. Taber, 2020, BMC Cardiovascular Disorders.

Impact of Race and Location of Residence on Statin Treatment Among Veterans With Type 2 Diabetes Mellitus.

R. Axon, M. Gebregziabher, D. Taber, 2020, The American journal of cardiology.

Optimizing finite resources: Pharmacist chart reviews in an outpatient kidney transplant clinic.

T. Srinivas, P. Baliga, D. Taber, 2015, Journal of the American Pharmacists Association.

The effect of Share 35 on biliary complications: An interrupted time series analysis

D. Axelrod, K. Chavin, D. Taber, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Ethnic and geographic variations in multimorbidty: Evidence from three large cohorts.

R. Axon, M. Gebregziabher, L. Egede, 2018, Social science & medicine.

Comorbid TBI-depression costs in veterans: a chronic effect of neurotrauma consortium (CENC) study

K. Yaffe, M. Gebregziabher, A. Byers, 2018, Brain injury.

Feasibility and Functional Testing for Frailty in Chronic Kidney Disease

M. Bergamin, J. C. Sieverdes, P. Baliga, 2018, Progress in transplantation.

Critical analysis of valganciclovir dosing and renal function on the development of cytomegalovirus infection in kidney transplantation

K. Chavin, D. Taber, N. Pilch, 2013, Transplant infectious disease : an official journal of the Transplantation Society.

Long-term assessment of NSAID prescriptions and potential nephrotoxicity risk in adult kidney transplant recipients.

M. Gebregziabher, D. Taber, Cory E Fominaya, 2019, Transplantation.

Clinical Outcomes of Older Kidney Transplant Recipients.

D. Taber, Prince K. Amaechi, K. Soliman, 2021, The American journal of the medical sciences.

Development and future deployment of a 5 years allograft survival model for kidney transplantation

T. Srinivas, D. DuBay, J. Bian, 2019, Nephrology.

Improving Transplant Medication Safety Through a Technology and Pharmacist Intervention (ISTEP): Protocol for a Cluster Randomized Controlled Trial (Preprint)

M. Gebregziabher, D. Taber, Cory E Fominaya, 2019 .

Improvement in immunosuppression therapy monitoring in organ transplant recipients

D. Taber, Cory E Fominaya, S. Thrall, 2017, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Quantifying the Race Stratified Impact of Socioeconomics on Graft Outcomes in Kidney Transplant Recipients

M. Gebregziabher, L. Egede, T. Srinivas, 2016, Transplantation.

Early Assessment of National Kidney Allocation Policy Change.

A. Lin, D. DuBay, P. Baliga, 2022, Journal of the American College of Surgeons.

Kidney and liver transplantation

D. Taber, R. Dupuis, 2013 .

Development of a Predictive Model for Drug‐Related Problems in Kidney Transplant Recipients

T. Srinivas, D. Taber, H. Meadows, 2017, Pharmacotherapy.

Cardiovascular Drug Shortages

B. Wiggins, D. Taber, C. Fortier, 2014, The Annals of pharmacotherapy.

Protocol‐based nurse coordinator management of ambulatory tacrolimus dosing in de novo renal transplant recipients—A single‐center experience with a large African American population

D. DuBay, P. Baliga, D. Taber, 2019, Clinical transplantation.

Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease Exceptions.

P. Baliga, P. Mauldin, D. Taber, 2018, Journal of the American College of Surgeons.

Management of Hypertension in Renal Transplant Patients: A Comprehensive Review of Nonpharmacologic and Pharmacologic Treatment Strategies

D. Taber, B. Hemstreet, N. Weimert, 2010, The Annals of pharmacotherapy.

A viewpoint describing the American Society of Transplantation rationale to conduct a comprehensive patient survey assessing unmet immunosuppressive therapy needs

L. Myaskovsky, D. Taber, W. Fitzsimmons, 2022, Clinical Transplantation.

Transplant Center Variability in Disparities for African-American Kidney Transplant Recipients

M. Gebregziabher, L. Egede, T. Srinivas, 2018, Annals of transplantation.

Long-term outcome of sirolimus rescue in kidney-pancreas transplantation.

J. Rogers, A. Lin, K. Chavin, 2004, Transplantation Proceedings.

A Randomized Controlled Clinical Trial

D. Salsburg, M. Gebregziabher, D. Taber, 2016 .

The effect of targeted insurer-mandated prescription monitoring on opioid prescribing patterns.

J. McCauley, P. Mauldin, D. Taber, 2020, Journal of the American Pharmacists Association : JAPhA.

Implementation of a collaborative drug therapy management service for inpatients receiving direct thrombin inhibitors.

J. Mazur, D. Taber, Tanna B Cooper, 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Assessment of risk factors for increased resource utilization in kidney transplantation.

K. Chavin, D. Taber, J. McGillicuddy, 2018, The Journal of surgical research.

Blue urticaria: a previously unreported adverse event associated with isosulfan blue.

T. Sadiq, D. Ollila, D. Taber, 2001, Archives of surgery.

Transplant clinical pharmacy services improve cardiovascular risk factor management and control in Veteran organ transplant recipients

D. Taber, Eric Schumann, Zana Elmaasarani, 2021, JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.

Comparison of efficacy of induction therapy in low immunologic risk African‐American kidney transplant recipients

M. Egidi, A. Lin, C. Bratton, 2010, Transplant international : official journal of the European Society for Organ Transplantation.

Effectiveness of an Evidence‐Based Induction Therapy Protocol Revision in Adult Kidney Transplant Recipients

K. Chavin, P. Baliga, D. Taber, 2017, Pharmacotherapy.

Big Data and Kidney Transplantation: Basic Concepts and Initial Experiences

Amit K. Mathur, David J. Taber, Titte R. Srinivas, 2017 .

A Randomized Control Trial Testing a Medication Safety Dashboard in Veteran Transplant Recipients

D. Taber, D. Cooney, S. Milfred-LaForest, 2023, Progress in transplantation.

Results of a Multicenter Cluster-Randomized Controlled Clinical Trial Testing the Effectiveness of a Bioinformatics-Enabled Pharmacist Intervention in Transplant Recipients.

R. Axon, M. Gebregziabher, D. Taber, 2023, American Journal of Transplantation.

MILLER Banding Procedure for Treatment of Dialysis Access–Related Steal Syndrome, Pulmonary Hypertension, and Heart Failure

A. Lin, D. Taber, V. Rohan, 2021, The American surgeon.

Impact of the New Kidney Allocation System on Perioperative Outcomes and Costs in Kidney Transplantation.

C. Bratton, K. Chavin, P. Baliga, 2017, Journal of the American College of Surgeons.

Induction therapy: clinical and quality of life outcomes in aged renal transplant recipients

K. Chavin, S. Nadig, D. Taber, 2015, Clinical transplantation.

Facilitated Regional Collaboration and In-Hospital Surgical Complication.

M. Gebregziabher, P. Baliga, P. Mauldin, 2020, Journal of the American College of Surgeons.

Sustainability of Improvements in Medication Adherence through a Mobile Health Intervention

F. Treiber, K. Chavin, P. Baliga, 2015, Progress in transplantation.

Lithium Dosing Equations

J. Borckardt, D. Taber, Shannon J Drayton, 2014, The Annals of pharmacotherapy.

The use of drotrecogin alfa (activated) in solid organ transplant patients: a case series

A. Lin, K. Chavin, P. Baliga, 2009, Transplant infectious disease : an official journal of the Transplantation Society.